Literature DB >> 8572146

Application of split-thickness skin grafts for acquired diseases of the external auditory canal.

W S McCary1, T C Kryzer, P R Lambert.   

Abstract

Over the past 10 years a variety of acquired external auditory canal pathologies have been treated at the University of Virginia. Surgical intervention has been required in 16 patients (18 ears). The most common diagnosis in this group was canal stenosis. Split-thickness skin grafts have been used for epithelial coverage. Depending on the size and location of the canal defect, one of three graft types was used: island, segmental, or circumferential. Surgical techniques are discussed and illustrative cases presented. Long-term graft results have been excellent, with no patient requiring a second graft for coverage. In those patients with preoperative conductive losses, the average improvement in hearing threshold was 27 decibels.

Entities:  

Mesh:

Year:  1995        PMID: 8572146

Source DB:  PubMed          Journal:  Am J Otol        ISSN: 0192-9763


  4 in total

1.  Our Experience of Treating Wide Spectrum of External Ear Canal Atresia of Different Etiologies in Pediatric Patients.

Authors:  Kranti Bhavana
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2017-05-11

2.  Auricular Split-Thickness Skin Graft for Ear Canal Coverage.

Authors:  Yarah M Haidar; Sartaaj Walia; Ronald Sahyouni; Yaser Ghavami; Harrison W Lin; Hamid R Djalilian
Journal:  Otolaryngol Head Neck Surg       Date:  2016-09-13       Impact factor: 3.497

3.  Prosthetic management of posttraumatic external auditory canal atresia: A rare cause of conductive hearing loss.

Authors:  A R Adhershitha; S Anilkumar; C Rajesh; Deepak C Mohan
Journal:  J Indian Prosthodont Soc       Date:  2016 Oct-Dec

4.  A Novel Use of Modified Tracheostomy Tubes in Preventing External Auditory Canal Stenosis.

Authors:  Chong Sian Ng; Seong Kin Foong; Siow Ping Loong; Cheng Ai Ong; Noor Dina Hashim
Journal:  J Int Adv Otol       Date:  2021-07       Impact factor: 1.017

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.